Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX in Healthy Male Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess safety, tolerability, pharmacokinetics, and pharmacodynamics of BIRT 2584 XX in
single rising oral doses of 5 mg to 700 mg in a polyethylene glycol 400 (PEG 400) solution in
healthy subjects